Nevro to Present at the 2015 Leerink Global Healthcare Conference

News provided by

Jan 28, 2015, 04:01 ET

MENLO PARK, Calif., Jan. 28, 2015 /PRNewswire/ -- Nevro Corp. (NYSE:NVRO), a medical device company that has developed and commercialized an innovative, evidence-based neuromodulation platform for the treatment of chronic pain, today announced that its management will be presenting at the 2015 Leerink Global Healthcare Conference on Wednesday, February 11^th in New York City.

Nevro management is scheduled to present at 3:30 p.m. ET. Individuals interested in listening to the presentation can access the live audio webcast on the "Investors" section of the company's website at: www.nevro.com. An archived presentation will be available on the website for two weeks.

About Nevro

Headquartered in Menlo Park, California, Nevro is a medical device company focused on providing innovative products that improve the quality of life of patients suffering from debilitating chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The Senza system is the only SCS system that delivers Nevro's proprietary HF10™ therapy. In the United States, the Senza system is limited by federal law to investigational use only. Senza, HF10, Nevro and the Nevro logo are trademarks of Nevro.

SOURCE Nevro Corp.